SPDR S&P 500 (SPY): -0.2%
iShares S&P 500 (IVV): -0.2%
PowerShares QQQ (QQQ): -0.2%
iShares Russell 2000 (IWM): -0.4%
iShares Russell 1000 Growth (IWF): -0.01%
iShares MSCI Emerging Markets Index (
United States Oil Fund (USO): -0.5%
Pre-Market ETF Most Actives:
Winners and Losers
Broad-market exchange traded funds are seeing pressure ahead of
the opening bell, with QQQ, SPY and IWM all sitting in the red as
investors remain firmly focused on Greece's debt problems and
several economic reports, including the weekly jobless claims and
May housing starts, on tap. Across the pond, Greece Prime Minister
George Papandreou is looking to reorganize his cabinet in bid to
gain support for the latest austerity package in that country.
Active tech shares are broadly lower. Among those stocks moving
this morning: Apple (
), down 0.3%; Intel (INTC), down 0.6%; Microsoft (MSFT), down 0.1%;
), down 0.3%; Google (GOOG), down 0.2%.
Shares of networking equipment maker Finisar Corp. (
) are down sharply after the company reported late yesterday that
fiscal Q4 non-GAAP EPS was $0.33 compared to $0.22 a year earlier,
meeting the Thomson Reuters mean analyst estimate. Revenues were
$236.9 million, 25.7% greater than the prior year period. The
Street expected $242 million. For Q1, the company is guiding for
revenue in the range of $221 to $236 mln and EPS of about $0.16 to
$0.20 per share. The Street is at $252 mln in revenue and earnings
of $0.36 per share.
Technology Select Sector SPDR (XLK), iShares Dow Jones US
Technology (IYW) is setting up for flat to lower action. Software
), iShares S&P GSTI Software Index Fund (IGV), Merrill Lynch
Internet Architecture HOLDRs (IAH), Morgan Stanley Technology (MTK)
and First Trust Nasdaq 100 Technology (QTEC) are lightly and flat
in pre-market trading.
Leading healthcare shares are lower in pre-market action. Pfizer
(PFE) is down 0.6%. Johnson & Johnson (JNJ) is down 0.2%.
The US Food and Drug Administration is weighing in on several
drugs this morning. Shares of Bristol Myers Squibb (BMY) are higher
after the company said that the U.S. Food & Drug Administration
has approved Kidney transplant drug NULOJIX. Also, Aegerion
Pharmaceuticals (AEGR) says it concluded a pre-new drug application
meeting with the FDA related to its investigational drug candidate,
lomitapide, for the treatment of homozygous familial
hypercholesterolemia (HoFH). Following the meeting, the company
said it intends to proceed with its NDA submission as previously
SPDR S&P Pharmaceuticals (XPH), PowerShares Dynamic
Pharmaceuticals (PJP) and Pharmaceutical HOLDRs (PPH) are all
seeing mild interest ahead of the open.
Commodities and Mining -
SPDR Gold Shares (GLD) is down 0.03%. Market Vectors Gold Miners
(GDX) is down 0.6%. iShares Silver Trust (SLV) is down 0.6%.
ProShares UltraShort Silver (ZSL) is up 1.6% and remains an
Power Play -
Watch retail and consumer ETFs through the day with earnings
coming from several sector names. Pier 1 Imports (PIR) says it
earned $0.12 per share in Q1. Sales were $334.603 million. A survey
of analysts by FactSet Research produced consensus estimates of
$0.11 a share of profit on $335.6 million of revenue. Also,
Smithfield Foods (SFD) says Q4 adjusted EPS were $0.85 on sales of
$3.1 billion. Analysts on average were expecting a profit of $0.82
a share on revenue of $3.23 billion, according to Thomson Reuters.
The company also said its board has authorized it to buy back up to
$150 million of common stock over the next two years.
In consumer ETFs, SPDR S&P Retail (XRT) is tilting to the
downside, now trading down 0.02%. The Direxion Daily Retail Bull
(RETL) and Consumer Staples Select Sect. SPDR (XLP) are seeing
moderate interest in the pre-market session.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.